Mobileye's Smaller Quarterly Loss Leans On A $52 Million Israeli Grant Paid Years From Now
The $162 million nine-month incentive sits as an asset, not cash, while third-quarter revenue slipped $12 million.
Mobileye's third-quarter operating loss narrowed to $82 million from $109 million a year earlier, and the company's 10-Q credits a $52 million Israeli research incentive booked as a cut to R&D spending. Revenue fell $12 million to $492 million in the quarter, and the cash behind the grant is not expected until 2028.
A grant booked as an asset
Mobileye, which develops driver-assistance and autonomous-driving technology, recognized $162 million of the incentive over the first nine months, up from $110 million in its prior quarterly filing. The amount sits in other long-term assets, which rose to $371 million from $175 million at year-end.
The filing says that asset growth helped pull nine-month operating cash flow down to $303 million from $489 million a year earlier. In its earnings release, the company said cash receipts for the 2026 benefit are expected to begin in 2028, about two years after accounting recognition.
The law was enacted March 29, 2026, and creates a refundable credit on qualifying Israeli R&D spending. It can be offset against Israeli taxes, or an unused amount can be received in cash after a carryforward period. The filing warns that changes to the law, or to Intel's status as controlling shareholder, could alter the amount.
Underlying R&D spending rose
Net R&D was $284 million in the quarter, against $304 million a year earlier. The 10-Q attributes the decline mainly to the $52 million grant, partly offset by higher stock compensation and payroll costs. Without the grant, quarterly R&D would have been about $336 million, above the year-earlier figure.
Stock-based compensation in R&D rose to $81 million from $62 million.
China pricing trims the margin
Adjusted gross margin fell to 64% from 67%, which the filing blames on lower-priced EyeQ chip sales to Chinese automakers and a costlier chip mix. Average system price fell 5%. SuperVision revenue dropped $4 million on lower volume, and EyeQ revenue fell $6 million.
Standard gross margin rose to 53% from 48%, because amortization of acquired intangibles shrank by $42 million. For nine months, revenue rose 8% to $1,558 million, but the net loss reached $3,906 million, dominated by a $3,788 million non-cash goodwill impairment in the first quarter.
Mobileye narrowed its full-year revenue outlook to $1,995 million to $2,020 million. The stock closed at $6.41 on Thursday, for a market value of about $6.0 billion.
The fourth-quarter report will show whether the incentive keeps offsetting rising research costs, while the grant's cash arrives no sooner than 2028.
Sources
- 10-Q Filing — Mobileye Global (MBLY) — SEC EDGAR
- 10-Q Filing — Mobileye Global (MBLY), Q2 FY2026 filed 2026-07-23 (comparison basis) — SEC EDGAR
- Earnings release (8-K Item 2.02, tm2628197d1_ex99-1.htm) — Mobileye Global, filed 2026-10-29 — SEC EDGAR
- 8-K/A Filing — Mobileye Global, filed 2026-10-29 (Items 5.02, 9.01) — SEC EDGAR
- Mobileye Global (MBLY) Q3 Earnings and Revenues Beat Estimates — Yahoo Finance
- Mobileye (MBLY) Reports Q3 Earnings: What Key Metrics Have to Say — Yahoo Finance
- Mobileye Sees Chinese Automaker Pricing Pressure Easing in 2027 — benzinga.com
- Mobileye Global Q3 2026 Earnings Call Transcript — benzinga.com
- Mobileye slides even as it tweaks full-year guidance on SuperVision strength (MBLY:NASDAQ) | Seeking Alpha — seekingalpha.com